reports
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financ...
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income(1) of $161 Million, Representing 35% Year-Over-Year Growth FY 2025 Adjusted EBITDA(2) of $231 Million, Representing 40% Year-Over-Year Growth Incoming CFO Appointment Expected to Further Enhance Financial Strategy, Working Capital Execution and Capital Allocation Discipline Advancing SG-00...
Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2025 Conf...
Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2025 Conference Call LUXEMBOURG, Feb. 19, 2026 (GLOBE NEWSWIRE) -- On Wednesday, March 4, 2026, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the fourth quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EST on the same day to discuss its fourth quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor...
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial R...
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 Conference Call Scheduled for February 25, 2026, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report fourth quarter and full year 2025 financial results on February 25, 2026, after the U.S. financial markets close. ADMA’s manag...
Altisource Names Rick Seehausen President of Lenders One
Altisource Names Rick Seehausen President of Lenders One Industry veteran to lead Altisource’s Origination segment and help shape the Company’s strategic growth LUXEMBOURG, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading provider of real estate and mortgage solutions, today announced the appointment of Rick Seehausen as President of Lenders One®. In this role, Mr. Seehausen will lead the strategic direction and day-to-day operations of Altisource’s Origination segment, including the delivery of Altisource’...
Statebridge Company Selects Equator® to Support Growing REO Asset Mana...
Statebridge Company Selects Equator® to Support Growing REO Asset Management Operations Mortgage servicer adopts Equator to manage residential & business purpose REO inventory. LUXEMBOURG, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Equator®, an Altisource® (NASDAQ: ASPS) business unit and a leading SaaS platform for residential real estate management, today announced that Statebridge Company, a mortgage servicer specializing in non-agency, GSE portfolios and Business Purpose loans, has selected Equator as its platform to manage REO operations. Equator powers end‑to‑end residential asset managem...
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Re...
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update FY 2025 Preliminary Unaudited Total Revenue of Approximately $510–511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA(1) and Adjusted Net Income(2) Guidance Reiterated Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of ~$40 Million in 4Q 2025 2026 Expected to be ADMA’s First Full Year of Yield-Enhanced Production, Supporting Anticipated Sustained Margin Expansion Strategic Plasma Network Repositi...
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on ...
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 RAMSEY, N.J. and BOCA RATON, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S.-based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Adam Grossman, President and Chief Executive Officer, will participate in a podium presentation at the J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 9:45 a.m. PT. A live audio webcast of the call w...
Lenders One Reports Strong Sales Momentum in Origination Solutions
Lenders One Reports Strong Sales Momentum in Origination Solutions Estimated $15 Million in Annual Closed-Won Contracts and Expanding Late-Stage Pipeline with over 39 Prospects LUXEMBOURG, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading provider of real estate and mortgage solutions, today announced significant sales momentum in its Origination Solutions business, driven by strong demand for Lenders One® Credit (“L1 Credit”) and Lenders One® Verification (“L1 Verification”) services. The Company recently si...
First Interstate Bancsystem Inc: 1 director
A director at First Interstate Bancsystem Inc sold 30,432 shares at 31.030USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SHOO STEVEN MADDEN LTD.
NTRA NATERA
MMS MAXIMUS INC.
ISRG INTUITIVE SURGICAL INC.
HOO HERBALIFE NUTRITION LTD.
HIG HARTFORD FINANCIAL SERVICES GROUP INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
BIIB BIOGEN INC.
ADMA ADMA BIOLOGICS INC
D4V G. WILLI-FOOD INTERNATIONAL LTD.
LZB LAZBOY INCORPORATED
HOFT HOOKER FURNITURE CORP.
TNDM TANDEM DIABETES CARE
RCUS ARCUS BIOSCIENCES
CSTL CASTLE BIOSCIENCES
TXG 10X GENOMICS INC CLASS A
NRIX NURIX THERAPEUTICS
ADPT ADAPTIVE BIOTECHNOLOGIES
TYRA TYRA BIOSCIENCES INC
GFR GREENFIRE RESOURCES LTD
SOLV_w SOLVENTUM CORPORATION
PACS PACS GROUP INC
NUTX NUTEX HEALTH INC
BBNX BETA BIONICS
KLRS KALARIS THERAPEUTICS INC
CCHH CCH HOLDINGS LTD
FBRX FORTE BIOSCIENCES INC
ADMA Biologics Announces Third Quarter 2025 Financial Results and Prov...
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update 3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA(1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income(2) of $38.9 Million, an 8% YoY Increase FDA Lot Release of First Yield-Enhanced Production Batches Positions ADMA for Margin Expansion Beginning in 4Q 2025 and Continuing Through 2026 Positive, Statistically Significant Real-World Health Outcomes Demonstrated for ASCENIV™ Record ASCE...
ADMA Biologics to Report Third Quarter 2025 Financial Results on Novem...
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report third quarter 2025 financial results on November 5, 2025, after the U.S. financial markets close. ADMA’s management team will host a live confe...
Altisource Announces Form S-3 Filing Related to Shares Previously Issu...
Altisource Announces Form S-3 Filing Related to Shares Previously Issued to Lenders LUXEMBOURG, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, filed a Form S-3 Registration Statement with the Securities and Exchange Commission on October 24, 2025 related to the registration of the resale of the shares previously issued to its lenders under the Securities Act of 1933, as amended (the “Form S-3”). On February 19, 2025, Altisource entered int...
Altisource Announces Third Quarter 2025 Financial Results
Altisource Announces Third Quarter 2025 Financial Results LUXEMBOURG, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the third quarter 2025. “We delivered solid third quarter performance. We grew Service revenue and improved pre-and post-tax GAAP earnings, GAAP earnings per share, and cash flow from operations compared to the third quarter of last year. This is largely from our focus on growing our busi...
Altisource Portfolio Solutions S.A. Schedules Third Quarter 2025 Conf...
Altisource Portfolio Solutions S.A. Schedules Third Quarter 2025 Conference Call LUXEMBOURG, Oct. 20, 2025 (GLOBE NEWSWIRE) -- On Thursday, October 23, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the third quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its third quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
XENE XENON PHARMACEUTICALS INC
SEDG SOLAREDGE TECHNOLOGIES INC.
RUN SUNRUN INC.
LTRX LANTRONIX INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
LAKE LAKELAND INDUSTRIES INC.
CEVA CEVA INC.
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ALB ALBEMARLE CORPORATION
EFR ENERGY FUELS
RELL RICHARDSON ELECTRONICS LTD.
NTLA INTELLIA THERAPEUTICS INC.
UAMY UNITED STATES ANTIMONY CORP.
BOMN BOSTON OMAHA
ICL ICL GROUP LTD.
LWLG LIGHTWAVE LOGIC
IMTX IMMATICS N V (A)
ARRY ARRAY TECHNOLOGIES
IMVT IMMUNOVANT
RLAY RELAY THERAPEUTICS
FLUX FLUX POWER HOLDINGS
GLUE MONTE ROSA THERAPEUTICS INC
ASTS AST SPACEMOBILE INC
TRDA ENTRADA THERAPEUTICS INC
JANX JANUX THERAPEUTICS INC
APLD APPLIED BLOCKCHAIN INC
IE IVANHOE ELECTRIC INC
NUVL NUVALENT INC
COHR COHERENT CORP
CRML CLAL INDUSTRIES & BEVERAGES LTD
GPCR STRUCTURE THERAPEUTICS
OCS OCULIS HOLDING AG
LAES SEALSQ CORP
NB NIOCORP DEVELOPMENTS LTD.
METBV FORTREA HOLDINGS INC.
FTREV SAGIMET BIOSCIENCES INC
SGMT BYRNA TECHNOLOGIES INC
BYRN ENGENE HOLDINGS INC
ENGN SPYRE THERAPEUTICS INC.
SYRE NEUROGENE INC
NGNE RAMACO RESOURCES INC.
METC TOYO CO LTD
TOYO SERVE ROBOTICS INC
SERV UPSTREAM BIO INC
UPB CIDARA THERAPEUTICS INC.
CDTX AMERICAN BATTERY TECHNOLOGY COMPANY
ABAT TVARDI THERAPEUTICS INC
TVRD USA RARE EARTH INC
USAR HYCROFT MINING HOLDING CORPORATION
HYMC CATALYST PERINI STRATEGIC INCOM ORD
CSIOX CHARGEPOINT HOLDINGS INC.
CHPT KULR TECHNOLOGY GROUP INC.
KULR GRAFTECH INTERNATIONAL LTD.
EAF GLOBALSTAR INC.
GSAT INHIBRX BIOSCIENCES INC.
INBX KON TUM CONSTRUCTION MATERIALS ORD
Equator Expands Customer Network with Leading Real Estate and Mortgage...
Equator Expands Customer Network with Leading Real Estate and Mortgage Companies Leading firms choose Equator to leverage advanced automation and customizable workflows for more efficient property lifecycle management LUXEMBOURG, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Equator®, an Altisource® (NASDAQ: ASPS) business and a leading SaaS platform for real estate transaction management, today announced the addition of four prominent organizations to its growing list of customers, including Renovo Financial (RF Mortgage Services Corporation) and HGF Management. These companies join a robust netw...
ADMA Biologics Announces Second Quarter 2025 Financial Results and Pro...
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of $50.8 Million, a 59% YoY Increase Excluding a Prior-Year Non-Recurring Item 2Q 2025 Adjusted Net Income(2) of $36.0 Million, an 85% YoY Increase Excluding a Prior-Year Non-Recurring Item Initiated Commercial-Scale Manufacturing with FDA-Approved Yield Enhancement Process; Initial Ba...
ADMA Biologics to Report Second Quarter 2025 Financial Results on Augu...
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report second quarter 2025 financial results on August 6, 2025, after the U.S. financial markets close. ADMA’s management team will host a live conferen...
Altisource Announces Second Quarter 2025 Financial Results
Altisource Announces Second Quarter 2025 Financial Results LUXEMBOURG, July 24, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the second quarter 2025. “We are pleased with our second quarter performance. In a close to historically low delinquency environment, we grew Service revenue, Adjusted EBITDA(1), pre- and post-tax GAAP earnings and GAAP earnings per share compared to the second quarter of last year. This...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.